Axon Enterprise's Expenses are on the Rise: Will It Affect Margins?

Axon Enterprise (AXON) reported a rise in Q1 2025 costs, with cost of sales increasing 18.2% and SG&A expenses jumping 48% year-over-year, driven by business integration, increased headcount, and higher compensation. Despite these cost pressures, AXON's adjusted gross margin improved to 63.6%, and adjusted EBITDA margin rose to 25.7%, fueled by strong sales of TASER 10, Axon Body 4, and platform sensor products; the company expects full-year adjusted EBITDA margin of approximately 25%. AXON realigned its business segments in Q1 to improve cost control and enhance margin performance.

Analysis

Axon Enterprise (AXON) demonstrated robust top-line growth and margin expansion in Q1 2025 despite significant cost pressures. The company reported an 18.2% year-over-year increase in cost of sales and a substantial 48% year-over-year jump in SG&A expenses, attributed to business integration activities, increased headcount, and higher compensation costs. Notwithstanding these escalating expenses, AXON achieved an adjusted gross margin of 63.6%, an improvement of 40 basis points, and an adjusted EBITDA margin of 25.7%, up from 23.7% in the prior-year period. This margin strength was driven by a 31.3% year-over-year revenue increase to $603.6 million, fueled by strong sales of its TASER 10, Axon Body 4, and platform sensor products. Management anticipates an adjusted EBITDA margin of approximately 25% for the full year 2025, with expected adjusted EBITDA between $650-$675 million. A strategic realignment of business segments initiated in Q1 2025 is intended to enhance cost control and support ongoing margin improvement. This performance contrasts with peers Kratos Defense & Security Solutions (KTOS) and Teledyne Technologies (TDY), both of which experienced rising costs and declining gross margins in Q1 2025. AXON's shares have significantly outperformed the industry, surging 181.1% in the past year. However, the company trades at a very high forward price-to-earnings ratio of 1,195.30X, far exceeding the industry average of 45.34X, and carries a Zacks Value Score of F, indicating a premium valuation. The Zacks Consensus Estimate for AXON’s 2025 earnings has trended upwards over the past 60 days, and the stock currently holds a Zacks Rank #3 (Hold).

Key Decisions for Investors

• Investors should acknowledge Axon's strong operational execution and positive earnings outlook, but exercise caution given its exceptionally high valuation multiples and significant recent share price appreciation.
• Closely monitor the impact of the Q1 business realignment on sustained cost management and margin trajectory in upcoming quarters, as this will be critical for justifying the current premium valuation.
• While Axon's ability to expand margins amidst rising costs, unlike peers KTOS and TDY, is a positive differentiator, the elevated valuation warrants a careful assessment of the risk/reward profile, particularly if broader market or industry conditions shift.